Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q2 2023 Earnings Call Transcript

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q2 2023 Earnings Call Transcript August 3, 2023

Intra-Cellular Therapies, Inc. misses on earnings expectations. Reported EPS is $-0.45 EPS, expectations were $0.62.

Operator: Good morning. And welcome to Intra-Cellular Therapies Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] As a...